<DOC>
	<DOC>NCT01227252</DOC>
	<brief_summary>This is a Phase 1 study in healthy subjects to evaluate the safety and tolerability of LY2886721 multiple doses, how the body handles the drug, and the drug's effect on the body.</brief_summary>
	<brief_title>A Safety Study of LY2886721 Multiple Doses in Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<criteria>Healthy men and nonchildbearing potential women Body mass index between 18.032.0 kg/m2 Are reliable and willing to make yourself available for the duration of the study and are willing to follow study procedures and research unit policies Taking overthecounter or prescription medication with the exception of vitamins or minerals Smoke more than 10 cigarettes per day Drink more than 5 cups of caffeine containing beverages (e.g., coffee, tea) per day</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>